Emerging role of polymorphisms of the MTHFR gene in systemic carcinogenesis besides their role in migraines

Headache

Volumn 52, Issue 8, 2012, Pages 1322-1323

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; METHYLENETETRAHYDROFOLIC ACID; PROTEIN P53; XRCC3 PROTEIN;

ALLELE; BLADDER CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; GENETIC POLYMORPHISM; HUMAN; LETTER; MIGRAINE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865839443     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02214.x     Document Type: Letter

References (8)

1. Stuart S, Cox HC, Lea RA, Griffiths LR,. The role of the MTHFR gene in migraine. Headache. In press.
2. Kouidhi S, Rouissi K, Khedhiri S, Ouerhani S, Cherif M, Benammar-Elgaaied A,. MTHFR gene polymorphisms and bladder cancer susceptibility: A meta-analysis including race, smoking status and tumour stage. Asian Pac J Cancer Prev. 2011; 12: 2227-2232.
3. Izmirli M, Inandiklioglu N, Abat D, et al,. MTHFR gene polymorphisms in bladder cancer in the Turkish population. Asian Pac J Cancer Prev. 2011; 12: 1833-1835.
4. Safarinejad MR, Shafiei N, Safarinejad S,. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: Association with risk for clear cell renal cell carcinoma and tumour behaviour in men. Clin Oncol (R Coll Radiol). 2012; 24: 269-281.
5. Zhu Q, Jin Z, Yuan Y, Lu Q, Ge D, Zong M,. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer. Scand J Gastroenterol. 2011; 46: 436-445.
6. Safarinejad MR, Shafiei N, Safarinejad S,. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: A case-control study. Prostate. 2010; 70: 1645-1657.
7. Ott K, Rachakonda PS, Panzram B, et al,. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Ann Surg Oncol. 2011; 18: 2688-2698.
8. Henriquez-Hernandez LA, Murias-Rosales A, Gonzalez-Hernandez A, de Leon AC, Diaz-Chico N, Fernandez-Perez L,. Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy. Cancer Epidemiol. 2010; 34: 634-638.